All entries for: Sage Therapeutics - Cambridge

July 30, 2025

Sage Therapeutics - Cambridge

Negative Outlook

Cambridge, MA
1-50 employees

We expect that litigation involving these and other provisions of the IRA will continue, with unpredictable and uncertain results. We further cannot predict with certainty what impact the IRA or any other federal or state health reforms will have on us, but such changes could impose new or more stringent regulatory requirements on our activities or result in reduced reimbursement for our products, any of which could adversely affect our business, results of operations and financial condition. There may be additional Congressional and administrative efforts to address drug pricing.

Disease Area: Multiple, Neurological Diseases, Psychiatry
Drug Type: Small Molecule
April 29, 2025

Sage Therapeutics - Cambridge

Negative Outlook

Cambridge, MA
1-50 employees

We further cannot predict with certainty what impact the IRA or any other federal or state health reforms will have on us, but such changes could impose new or more stringent regulatory requirements on our activities or result in reduced reimbursement for our products, any of which could adversely affect our business, results of operations and financial condition. There may be additional Congressional and administrative efforts to address drug pricing.

Disease Area: Multiple, Neurological Diseases, Psychiatry
Drug Type: Small Molecule
Scroll to Top